EP3206717
COMBINATION OF CERITINIB WITH AN EGFR INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.10.2015EP published:
25.11.2020EP application number:
15784975.3
EPO information:
European Patent Register
Max expiry date:
14.10.2035
Title:
COMBINATION OF CERITINIB WITH AN EGFR INHIBITOR
Timeline
Today
15.10.2015EP application
25.11.2020EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
BORAL, AnthonyAddress:
Cambridge, Massachusetts 02139, US
Name:
LI, FangAddress:
Cambridge, Massachusetts 02139, US
Name:
LI, NanxinAddress:
San Diego, California 92121, US
Name:
PANTANO, SerafinoAddress:
4002 Basel, CH
Priority
Number:
201462065451 PDate:
17.10.2014Country:
US
Number:
201462068175 PDate:
24.10.2014Country:
US
Number:
201462068945 PDate:
27.10.2014Country:
US
Number:
201562118710 PDate:
20.2.2015Country:
US
Classification
Categories:
A61K 31/4709, A61K 31/506, A61K 31/517, A61K 31/5377, C07K 16/32, A61K 39/395, A61K 45/06, A61P 35/00, A61K 31/519, A61K 31/55, A61K 31/4706